Dale Curtis Hogue Jr. - Jan 20, 2024 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Interim CEO, Director
Signature
/s/ Michael Wong, By PoA from Dale Curtis Hogue, Jr.
Stock symbol
TCRT
Transactions as of
Jan 20, 2024
Transactions value $
$0
Form type
4
Date filed
1/23/2024, 05:47 PM
Previous filing
Jan 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +600K $0.00 600K Jan 20, 2024 Common Stock 600K $0.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In twelve equal monthly installments measured from January 20, 2024, with the first vesting occurring on February 20, 2024, subject to the Reporting Person's continued service through each such date.